Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry|June 9, 2006
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanesYuxiang Dong, Yuanqing Tang, Jacques Chollet, et al.ACS Pharmacology & Translational Science|June 17, 2022
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin InhibitorsKate H Gartlan, Jagdish K Jaiswal, Matthew R Bull, et al.Journal of Medicinal Chemistry|July 22, 2005
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypesYuxiang Dong, Jacques Chollet, Hugues Matile, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised targetYongyuth Yuthavong, Bongkoch Tarnchompoo, Tirayut Vilaivan, et al.ACS Infectious Diseases|June 8, 2021
Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439David M Shackleford, Francis C K Chiu, Kasiram Katneni, et al.ACS Infectious Diseases|September 8, 2025
Identification of α-Azacyclic Acetamide-Based Inhibitors of <i>P. falciparum</i> Na<sup>+</sup> Pump (<i>Pf</i>ATP4) with Fast-Killing Asexual Blood-Stage Antimalarial Activity by Phenotypic ScreeningArturo Casas, Leah S Imlay, Vandana Thathy, et al.Nature|August 20, 2004
Identification of an antimalarial synthetic trioxolane drug development candidateJonathan L Vennerstrom, Sarah Arbe-Barnes, Reto Brun, et al.Journal of Medicinal Chemistry|November 21, 2009
The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan, et al.Biorxiv : the Preprint Server for Biology|June 6, 2025
Identification of α-azacyclic acetamide-based inhibitors of <i>P. falciparum</i> Na <sup>+</sup> pump ( <i>Pf</i> ATP4) with fast-killing asexual blood-stage antimalarial activity by phenotypic screeningArturo Casas, Leah S Imlay, Vandana Thathy, et al.ACS Infectious Diseases|October 18, 2024
Single-Dose Drug Development Candidate for SchistosomiasisDerek A Leas, Jennifer Keiser, Susan A Charman, et al.Pageof 18